Cancer metastasis accounts for the majority of cancer-related deaths and remains a clinical challenge. Metastatic cancer cells generally resemble cells of the primary cancer, but they may be influenced by the milieu of the organs they colonize. Here, we show that colorectal cancer cells undergo metabolic reprogramming after they metastasize and colonize the liver, a key metabolic organ. In particular, via GATA6, metastatic cells in the liver upregulate the enzyme aldolase B (ALDOB), which enhances fructose metabolism and provides fuel for major pathways of central carbon metabolism during tumor cell proliferation. Targeting ALDOB or reducing dietary fructose significantly reduces liver metastatic growth but has little effect on the primary tumor. Our findings suggest that metastatic cells can take advantage of reprogrammed metabolism in their new microenvironment, especially in a metabolically active organ such as the liver. Manipulation of involved pathways may affect the course of metastatic growth.
Using a perfusion decellularization protocol, we developed a
decellularized skin/adipose tissue flap (DSAF) comprising extracellular matrix
(ECM) and intact vasculature. Our DSAF had a dominant vascular pedicle,
microcirculatory vascularity, and a sensory nerve network and retained
three-dimensional (3D) nanofibrous structures well. DSAF, which was composed of
collagen and laminin with well-preserved growth factors (e.g., vascular
endothelial growth factor, basic fibroblast growth factor), was successfully
repopulated with human adipose-derived stem cells (hASCs) and human umbilical
vein endothelial cells (HUVECs), which integrated with DSAF and formed 3D
aggregates and vessel-like structures in vitro. We used
microsurgery techniques to re-anastomose the recellularized DSAF into nude rats.
In vivo, the engineered flap construct underwent
neovascularization and constructive remodeling, which was characterized by the
predominant infiltration of M2 macrophages and significant adipose tissue
formation at 3 months postoperatively. Our results indicate that DSAF
co-cultured with hASCs and HUVECs is a promising platform for vascularized soft
tissue flap engineering. This platform is not limited by the flap size, as the
entire construct can be immediately perfused by the recellularized vascular
network following simple re-integration into the host using conventional
microsurgical techniques.
Flexible epidermic sensors made from conductive hydrogels are holding bright potential in personalized healthcare, multifunctional electronic skins, and human‐machine interfaces. However, it is still a great challenge to simultaneously realize conductive hydrogel‐based epidermic sensors with reliable self‐healing ability and remarkable sensing performances in high‐performance healthcare (especially electrophysiological signals) sensing for wearable human‐machine interaction, as well as accelerated wound healing for subsequent medical treatment together. Herein, a flexible healable high‐performance epidermic sensor is assembled from the facilely prepared antibacterial MXene hydrogel with efficiently accelerated wound healing for sensitively wearable human‐machine interaction. The as‐prepared hydrogel possesses enhanced mechanical performance, outstanding healable capability, reliable injectability, facile degradability, excellent biocompatibility, and robust antibacterial ability, which is capable of being assembled into a multifunctional epidermic sensor to sensitively monitor human movements for rehabilitation training, to detect tiny electrophysiological signals for the diagnosis of cardiovascular‐ and muscle‐related diseases, and to be employed for wearable human‐machine interaction. In addition, the hydrogel can be utilized to treat wound infection and can effectively accelerate wound healing. Thus, it sheds light on preparing flexible healable epidermic sensors with multifunctional integration of personal health diagnosis and smart medical treatment for wearable human‐machine interaction and next‐generation artificial skins.
High mobility group box-B1 (HMGB1), an autophagy activator, is crucial in tumorigenesis. However, its extracellular role and signaling in gastric cancer remain unclear. Samples were collected from gastric cancer patients and healthy controls. Immunohistochemistry and immunocytochemistry were used to determine the localization of HMGB1 in gastric cancer tissues, four gastric carcinoma cell lines (BGC-823, SGC-7901, MKN-28 and MKN-45) and a gastric epithelial cell line GES-1. Western blot analysis and ELISA were used to assess the effects of gefitinib, an epidermal growth factor receptor inhibitor, on autophagy and HMGB1 release in BGC-823 cells. MTT assay and western blot analysis assessed the effects of extracellular HMGB1 on cell proliferation and signaling transduction. Released HMGB1 promoted proliferation through activation of ERK1/2 MAPK. HMGB1 expression in gastric cancer tissues and serum was significantly increased compared to the controls and healthy serum. Gastric carcinoma cells showed an increased HMGB1 in the nuclei and cytoplasm, whereas GES-1 cells exhibited a lower HMGB1 with nuclear localization. Gefitinib increased autophagy and cytoplasmic HMGB1 release from the BGC-823 cells. Extracellular HMGB1 in autophagic cell supernatant promoted proliferation that was abolished by glycyrrhizic acid, an HMGB1 inhibitor. BGC-823 cells incubated with HMGB1 had increased ERK1/2 phosphorylation, while levels of JNK, p38 or AKT were not affected. Blocking RAGE-HMGB1 interaction with antibody or siRNA suppressed the ERK1/2 activation and gastric cancer cell growth, indicating that RAGE-mediated ERK1/2 signaling was necessary for tumor progression.
Adipose-derived mesenchymal stem cells (AD-MSCs) have been shown to ameliorate hyperglycemia in diabetic animals and individuals. However, little is known about whether AD-MSCs affect lipid metabolism. Here we have demonstrated for the first time that AD-MSC infusion can significantly suppress the increase in body weight and remarkably improve dyslipidemia in db/db obese mice and diet-induced obesity mice. Induction of white fat tissue "browning" and activation of adenosine monophosphate-activated protein kinase and its downstream hormone-sensitive lipase in adipose tissue contribute to the antiobesity and lipid-lowering effects. Thus, AD-MSC infusion holds great therapeutic potential for dyslipidemia and associated cardiovascular diseases. STEM CELLS
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.